MENU
ADTX
AS OF
Dec 24 closing price
Price
$1.14
Change
-$0.12 (-9.52%)
Capitalization
2.02M
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
ADTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Aditxt (ADTX) Ownership - Who owns Aditxt?

Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
737 North Fifth Street
Phone
+1 650 870-1200
Employees
61
Web
https://www.aditxt.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.02M
P/E Ratio
N/A
Total Cash
163.04K
Projected Growth
N/A
Total Debt
5.67M
Revenue
5.95K
Risk (Beta)
1.29
Dividend Yield
N/A
Total Cash/Share
0.09
Total Debt/Equity
N/A
Revenue/Share
0.12 USD as % of share price

Fundamentals

ADTX
Capitalization
2.03M
P/E Ratio
N/A
Risk (Beta)
1.29
Dividend Yield
N/A
Total Cash
163K
Total Cash/Share
0.09
Total Debt
5.67M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.12%
Revenue
5.95K
ROE
N/A
Book Value
-7.73M
P/B Ratio
0.11
Cash Flow
N/A
Earnings
-829.59
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
51
Current Ratio
0.02
Current Revenue Per Employee
28.77
Dividends Per Share - Security
N/A
EBITDA
-40.39M
Float
N/A
Float - Current
N/A
Gross Income Margin
2.14
Revenue To Assets
-202.88
Shares Held By Institutions
24.8K
Shares Outstanding - Current
1.78M
Total Liabilities
20.7M
Total Volume MTD
N/A
Value
1
Gain YTD
-99.979
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ADTX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
View AI-Driven Trading for ADTX
A.I. Advisor
published General Information

General Information

a life sciences company which engages in the development of nucleic acid (DNA)-based technologies to minimize rejection of transplanted organs by human recipients as well as address autoimmune diseases and allergies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
737 North Fifth Street
Phone
+1 650 870-1200
Employees
61
Web
https://www.aditxt.com